Insights & Indicators

In this episode, Jason is joined by Bobby Schmidt, Co-Head of Global Healthcare at Carlyle, for a discussion about durable growth trends across healthcare, life sciences, and medtech, and what the record-setting Medline IPO may signal for exits in 2026.   Our research disclosure is available at https://www.carlyle.com/notices-and-disclaimers. 

In this special annual outlook episode of Insights & Indicators, Jason Thomas explores five questions for 2026 that highlight key forces shaping markets, policy, and investment opportunities in the year ahead.  Our research disclosure is available at https://www.carlyle.com/notices-and-disclaimers. 

Joining Jason in this episode is Chris Perriello, Global Head of Secondaries at Carlyle AlpInvest, to discuss developments in the private equity secondary market and how that market is evolving. Our research disclosure is available at https://www.carlyle.com/notices-and-disclaimers.

In this episode, Jason is joined by Lauren Basmadjian, Global Head of Liquid Credit at Carlyle, who identifies the bright signs she sees in today’s credit markets and what she expects for 2026. Our research disclosure is available at https://www.carlyle.com/notices-and-disclaimers.

In this episode, Jason is joined by Marc-Antoine Bouyer, Head of Carlyle Europe Realty, who shares his views of current investment opportunities and challenges in the European real estate market. Our research disclosure is available at https://www.carlyle.com/notices-and-disclaimers.